Higher cancer risk post CIN 3 treatment

Previous studies have shown that women previously treated for cervical intraepithelial neoplasia grade 3 (CIN 3) have an increased risk of developing cervical or vaginal cancer, and that this risk persists for at least 25 years.

However, no study has investigated how aging affects the risk of death from cervical cancer following treatment for CIN 3.

In this study, researchers used data from the Swedish Cancer Registry to follow 150,883 women diagnosed and treated for CIN 3 in the period